Edwards Lifesciences Corp

$70.95
(as of Feb 10, 12:28 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Edwards Lifesciences Corp

Stock Price
$70.96
Ticker Symbol
EW
Exchange
NYSE

Industry Information for Edwards Lifesciences Corp

Sector
Healthcare
Industry
Medical Devices

Company Description for Edwards Lifesciences Corp

Country
USA
Full Time Employees
19,800

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Fundamentals for Edwards Lifesciences Corp

Market Capitalization
$41,492,430,848
EBITDA
$2,052,400,000
Dividends per Share
P/E Ratio
27.16
Forward P/E Ratio
29.07
Earnings per Share
$2.59
Earnings per Share Estimate Next Year
$2.45
Profit Margin
65.86%
Shares Outstanding
589,800,000
Percent Owned by Insiders
1.40%
Percent Owned by Institutions
88.65%
52-Week High
$96.12
52-Week Low
$58.93

Technical Indicators for Edwards Lifesciences Corp

50-Day Moving Average
$72.30
200-Day Moving Average
$75.22
RSI
44.93
1.59

Analyst Ratings for Edwards Lifesciences Corp

Strong Buy
9
Buy
5
Hold
19
Sell
0
Strong Sell
0

News About Edwards Lifesciences Corp

Feb 8, 2025, 6:00 AM EST
Key Insights See more.
Feb 6, 2025, 5:45 PM EST
Mettler-Toledo (MTD) came out with quarterly earnings of $12.41 per share, beating the Zacks Consensus Estimate of $11.69 per share. See more.
Feb 6, 2025, 10:01 AM EST
Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when DexCom (DXCM) reports results for the quarter ended December 2024. See more.
Feb 6, 2025, 9:15 AM EST
In its upcoming report, Edwards Lifesciences (EW) is predicted by Wall Street analysts to post quarterly earnings of $0.55 per share, reflecting a decline of 14.1% compared to the same period last year. See more.
Feb 4, 2025, 11:40 AM EST
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Integer (ITGR) and Edwards Lifesciences (EW). See more.